Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Aug;34(8):1099–1101. doi: 10.1136/gut.34.8.1099

Anthranoid laxative abuse--a risk for colorectal cancer?

C P Siegers 1, E von Hertzberg-Lottin 1, M Otte 1, B Schneider 1
PMCID: PMC1374362  PMID: 8174962

Abstract

Anthranoid-containing laxatives--aloe, cascara, frangula, and rheum--may play a role in colorectal cancer. This risk is particularly important in view of the wide abuse of self administered laxatives for chronic constipation. There are data on the genotoxic potential of anthranoids and there is evidence of a tumourigenic potential in rodents. A case report and clinical-epidemiological studies have evaluated the cancer risk in patients who have abused anthranoid laxatives over a long period. Pseudomelanosis coli is a reliable parameter of chronic laxative abuse (> 9-12 months) and is specific for anthranoid drugs. In a retrospective study of 3049 patients who underwent diagnostic colorectal endoscopy the incidence of pseudomelanosis coli was 3.13% in patients without pathological changes. In those with colorectal adenomas, the incidence increased to 8.64% (p < 0.01), and in those with colorectal carcinomas it was 3.29%. This lower rate was probably caused by incomplete documentation of pseudomelanosis coli in those with carcinoma. In a prospective study of 1095 patients, the incidence of pseudomelanosis coli was 6.9% for patients with no abnormality seen on endoscopy, 9.8% (p = 0.068) for patients with adenomas, and 18.6% for patients with colorectal carcinomas. From these data a relative risk of 3.04 (1.18, 4.90; 95% confidence interval) can be calculated for colorectal cancer as a result of anthranoid laxative abuse.

Full text

PDF
1099

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOYD J. T., DOLL R. Gastro-intestinal cancer and the use of liquid paraffin. Br J Cancer. 1954 Jun;8(2):231–237. doi: 10.1038/bjc.1954.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown J. P., Brown R. J. Mutagenesis by 9,10-anthraquinone derivatives and related compounds in Salmonella typhimurium. Mutat Res. 1976 Jul;40(3):203–224. doi: 10.1016/0165-1218(76)90046-x. [DOI] [PubMed] [Google Scholar]
  3. Bruggeman I. M., van der Hoeven J. C. Lack of activity of the bacterial mutagen emodin in HGPRT and SCE assay with V79 Chinese hamster cells. Mutat Res. 1984 Nov-Dec;138(2-3):219–224. doi: 10.1016/0165-1218(84)90047-8. [DOI] [PubMed] [Google Scholar]
  4. Gardiner J. S., Walker S. A., MacLean A. J. A retrospective mortality study of substituted anthraquinone dyestuffs workers. Br J Ind Med. 1982 Nov;39(4):355–360. doi: 10.1136/oem.39.4.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kune G. A., Kune S., Field B., Watson L. F. The role of chronic constipation, diarrhea, and laxative use in the etiology of large-bowel cancer. Data from the Melbourne Colorectal Cancer Study. Dis Colon Rectum. 1988 Jul;31(7):507–512. doi: 10.1007/BF02553722. [DOI] [PubMed] [Google Scholar]
  6. Masuda T., Haraikawa K., Morooka N., Nakano S., Ueno Y. 2-Hydroxyemodin, an active metabolite of emodin in the hepatic microsomes of rats. Mutat Res. 1985 May;149(3):327–332. doi: 10.1016/0027-5107(85)90148-4. [DOI] [PubMed] [Google Scholar]
  7. Morgenstern L., Shemen L., Allen W., Amodeo P., Michel S. L. Melanosis coli. Changes in appearance when associated with colonic neoplasia. Arch Surg. 1983 Jan;118(1):62–64. doi: 10.1001/archsurg.1983.01390010048011. [DOI] [PubMed] [Google Scholar]
  8. Mori H., Sugie S., Niwa K., Takahashi M., Kawai K. Induction of intestinal tumours in rats by chrysazin. Br J Cancer. 1985 Nov;52(5):781–783. doi: 10.1038/bjc.1985.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mori H., Sugie S., Niwa K., Yoshimi N., Tanaka T., Hirono I. Carcinogenicity of chrysazin in large intestine and liver of mice. Jpn J Cancer Res. 1986 Sep;77(9):871–876. [PubMed] [Google Scholar]
  10. Mori H., Yoshimi N., Iwata H., Mori Y., Hara A., Tanaka T., Kawai K. Carcinogenicity of naturally occurring 1-hydroxyanthraquinone in rats: induction of large bowel, liver and stomach neoplasms. Carcinogenesis. 1990 May;11(5):799–802. doi: 10.1093/carcin/11.5.799. [DOI] [PubMed] [Google Scholar]
  11. Nakamura G. J., Schneiderman L. J., Klauber M. R. Colorectal cancer and bowel habits. Cancer. 1984 Oct 1;54(7):1475–1477. doi: 10.1002/1097-0142(19841001)54:7<1475::aid-cncr2820540743>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  12. Patel P. M., Selby P. J., Deacon J., Chilvers C., McElwain T. J. Anthraquinone laxatives and human cancer: an association in one case. Postgrad Med J. 1989 Apr;65(762):216–217. doi: 10.1136/pgmj.65.762.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SPEARE G. S. Melanosis coll; experimental observations on its production and elimination in twenty-three cases. Am J Surg. 1951 Nov;82(5):631–637. doi: 10.1016/0002-9610(51)90432-1. [DOI] [PubMed] [Google Scholar]
  14. Siegers C. P. Anthranoid laxatives and colorectal cancer. Trends Pharmacol Sci. 1992 Jun;13(6):229–231. doi: 10.1016/0165-6147(92)90070-m. [DOI] [PubMed] [Google Scholar]
  15. Steer H. W., Colin-Jones D. G. Melanosis coli: studies of the toxic effects of irritant purgatives. J Pathol. 1975 Apr;115(4):199–205. doi: 10.1002/path.1711150403. [DOI] [PubMed] [Google Scholar]
  16. Tikkanen L., Matsushima T., Natori S. Mutagenicity of anthraquinones in the Salmonella preincubation test. Mutat Res. 1983 Mar;116(3-4):297–304. doi: 10.1016/0165-1218(83)90067-8. [DOI] [PubMed] [Google Scholar]
  17. WITTOESCH J. H., JACKMAN R. J., McDONALD J. R. Melanosis coli: general review and a study of 887 cases. Dis Colon Rectum. 1958 May-Jun;1(3):172–180. doi: 10.1007/BF02616828. [DOI] [PubMed] [Google Scholar]
  18. Watanabe H., Numazawa M., Yamagata S. Analysis of 6,293 routine proctosigmoidoscopies. Tohoku J Exp Med. 1976 Jul;119(3):275–281. doi: 10.1620/tjem.119.275. [DOI] [PubMed] [Google Scholar]
  19. Westendorf J., Marquardt H., Poginsky B., Dominiak M., Schmidt J., Marquardt H. Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res. 1990 Jan;240(1):1–12. doi: 10.1016/0165-1218(90)90002-j. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES